Enter your terms above and click the 'Search' button.

Showing articles 0 to 6 of 6 Filter Applied: multiple sclerosis,treatment of (Click to remove) Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy Neurol 91:e359-e363, Rauer,S.,et al, 2018 Alemtuzumab for Multiples Sclerosis: Who and When to treat? Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012 Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009 Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases JAMA 291:2367-2375, Dalakas,M.C., 2004 Plasma Exchange for Severe Attacks of CNS: Demyelination: Predictors of Response Neurol 58:143-146, Keegan,M.,et al, 2002 Cladribine in Treatment of Chronic Progressive Multiple Sclerosis Lancet 344:3-13, Sipe,J.C.,et al, 1994 Showing articles 0 to 6 of 6